Medical Care
Global Monkeypox Therapeutics Market Research Report 2025
- Mar 11, 25
- ID: 77658
- Pages: 73
- Figures: 79
- Views: 16
The global market for Monkeypox Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Monkeypox Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monkeypox Therapeutics.
The Monkeypox Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monkeypox Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monkeypox Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chimerix Inc.
SIGA Technologies, Inc.
Emergent BioSolutions Inc.
Bavarian Nordic A/S
Hetero Drugs Limited
Mylan N.V.
Piramal Enterprises Limited
Olon S.p.A.
Teva Pharmaceutical Industries Limited
CIDIC Company Limited
Segment by Type
Smallpox Vaccine
Antivirals
Vaccinia Immune Globulin (VIG)
Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monkeypox Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Monkeypox Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monkeypox Therapeutics.
The Monkeypox Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monkeypox Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monkeypox Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chimerix Inc.
SIGA Technologies, Inc.
Emergent BioSolutions Inc.
Bavarian Nordic A/S
Hetero Drugs Limited
Mylan N.V.
Piramal Enterprises Limited
Olon S.p.A.
Teva Pharmaceutical Industries Limited
CIDIC Company Limited
Segment by Type
Smallpox Vaccine
Antivirals
Vaccinia Immune Globulin (VIG)
Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monkeypox Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monkeypox Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Smallpox Vaccine
1.2.3 Antivirals
1.2.4 Vaccinia Immune Globulin (VIG)
1.3 Market by Application
1.3.1 Global Monkeypox Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monkeypox Therapeutics Market Perspective (2020-2031)
2.2 Global Monkeypox Therapeutics Growth Trends by Region
2.2.1 Global Monkeypox Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Monkeypox Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Monkeypox Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Monkeypox Therapeutics Market Dynamics
2.3.1 Monkeypox Therapeutics Industry Trends
2.3.2 Monkeypox Therapeutics Market Drivers
2.3.3 Monkeypox Therapeutics Market Challenges
2.3.4 Monkeypox Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monkeypox Therapeutics Players by Revenue
3.1.1 Global Top Monkeypox Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Monkeypox Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Monkeypox Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Monkeypox Therapeutics Revenue
3.4 Global Monkeypox Therapeutics Market Concentration Ratio
3.4.1 Global Monkeypox Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monkeypox Therapeutics Revenue in 2024
3.5 Global Key Players of Monkeypox Therapeutics Head office and Area Served
3.6 Global Key Players of Monkeypox Therapeutics, Product and Application
3.7 Global Key Players of Monkeypox Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Monkeypox Therapeutics Breakdown Data by Type
4.1 Global Monkeypox Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Monkeypox Therapeutics Forecasted Market Size by Type (2026-2031)
5 Monkeypox Therapeutics Breakdown Data by Application
5.1 Global Monkeypox Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Monkeypox Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Monkeypox Therapeutics Market Size (2020-2031)
6.2 North America Monkeypox Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Monkeypox Therapeutics Market Size by Country (2020-2025)
6.4 North America Monkeypox Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monkeypox Therapeutics Market Size (2020-2031)
7.2 Europe Monkeypox Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Monkeypox Therapeutics Market Size by Country (2020-2025)
7.4 Europe Monkeypox Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monkeypox Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Monkeypox Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Monkeypox Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Monkeypox Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monkeypox Therapeutics Market Size (2020-2031)
9.2 Latin America Monkeypox Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Monkeypox Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Monkeypox Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monkeypox Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Monkeypox Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Monkeypox Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Monkeypox Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chimerix Inc.
11.1.1 Chimerix Inc. Company Details
11.1.2 Chimerix Inc. Business Overview
11.1.3 Chimerix Inc. Monkeypox Therapeutics Introduction
11.1.4 Chimerix Inc. Revenue in Monkeypox Therapeutics Business (2020-2025)
11.1.5 Chimerix Inc. Recent Development
11.2 SIGA Technologies, Inc.
11.2.1 SIGA Technologies, Inc. Company Details
11.2.2 SIGA Technologies, Inc. Business Overview
11.2.3 SIGA Technologies, Inc. Monkeypox Therapeutics Introduction
11.2.4 SIGA Technologies, Inc. Revenue in Monkeypox Therapeutics Business (2020-2025)
11.2.5 SIGA Technologies, Inc. Recent Development
11.3 Emergent BioSolutions Inc.
11.3.1 Emergent BioSolutions Inc. Company Details
11.3.2 Emergent BioSolutions Inc. Business Overview
11.3.3 Emergent BioSolutions Inc. Monkeypox Therapeutics Introduction
11.3.4 Emergent BioSolutions Inc. Revenue in Monkeypox Therapeutics Business (2020-2025)
11.3.5 Emergent BioSolutions Inc. Recent Development
11.4 Bavarian Nordic A/S
11.4.1 Bavarian Nordic A/S Company Details
11.4.2 Bavarian Nordic A/S Business Overview
11.4.3 Bavarian Nordic A/S Monkeypox Therapeutics Introduction
11.4.4 Bavarian Nordic A/S Revenue in Monkeypox Therapeutics Business (2020-2025)
11.4.5 Bavarian Nordic A/S Recent Development
11.5 Hetero Drugs Limited
11.5.1 Hetero Drugs Limited Company Details
11.5.2 Hetero Drugs Limited Business Overview
11.5.3 Hetero Drugs Limited Monkeypox Therapeutics Introduction
11.5.4 Hetero Drugs Limited Revenue in Monkeypox Therapeutics Business (2020-2025)
11.5.5 Hetero Drugs Limited Recent Development
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Details
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Monkeypox Therapeutics Introduction
11.6.4 Mylan N.V. Revenue in Monkeypox Therapeutics Business (2020-2025)
11.6.5 Mylan N.V. Recent Development
11.7 Piramal Enterprises Limited
11.7.1 Piramal Enterprises Limited Company Details
11.7.2 Piramal Enterprises Limited Business Overview
11.7.3 Piramal Enterprises Limited Monkeypox Therapeutics Introduction
11.7.4 Piramal Enterprises Limited Revenue in Monkeypox Therapeutics Business (2020-2025)
11.7.5 Piramal Enterprises Limited Recent Development
11.8 Olon S.p.A.
11.8.1 Olon S.p.A. Company Details
11.8.2 Olon S.p.A. Business Overview
11.8.3 Olon S.p.A. Monkeypox Therapeutics Introduction
11.8.4 Olon S.p.A. Revenue in Monkeypox Therapeutics Business (2020-2025)
11.8.5 Olon S.p.A. Recent Development
11.9 Teva Pharmaceutical Industries Limited
11.9.1 Teva Pharmaceutical Industries Limited Company Details
11.9.2 Teva Pharmaceutical Industries Limited Business Overview
11.9.3 Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Introduction
11.9.4 Teva Pharmaceutical Industries Limited Revenue in Monkeypox Therapeutics Business (2020-2025)
11.9.5 Teva Pharmaceutical Industries Limited Recent Development
11.10 CIDIC Company Limited
11.10.1 CIDIC Company Limited Company Details
11.10.2 CIDIC Company Limited Business Overview
11.10.3 CIDIC Company Limited Monkeypox Therapeutics Introduction
11.10.4 CIDIC Company Limited Revenue in Monkeypox Therapeutics Business (2020-2025)
11.10.5 CIDIC Company Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monkeypox Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Smallpox Vaccine
1.2.3 Antivirals
1.2.4 Vaccinia Immune Globulin (VIG)
1.3 Market by Application
1.3.1 Global Monkeypox Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monkeypox Therapeutics Market Perspective (2020-2031)
2.2 Global Monkeypox Therapeutics Growth Trends by Region
2.2.1 Global Monkeypox Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Monkeypox Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Monkeypox Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Monkeypox Therapeutics Market Dynamics
2.3.1 Monkeypox Therapeutics Industry Trends
2.3.2 Monkeypox Therapeutics Market Drivers
2.3.3 Monkeypox Therapeutics Market Challenges
2.3.4 Monkeypox Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monkeypox Therapeutics Players by Revenue
3.1.1 Global Top Monkeypox Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Monkeypox Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Monkeypox Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Monkeypox Therapeutics Revenue
3.4 Global Monkeypox Therapeutics Market Concentration Ratio
3.4.1 Global Monkeypox Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monkeypox Therapeutics Revenue in 2024
3.5 Global Key Players of Monkeypox Therapeutics Head office and Area Served
3.6 Global Key Players of Monkeypox Therapeutics, Product and Application
3.7 Global Key Players of Monkeypox Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Monkeypox Therapeutics Breakdown Data by Type
4.1 Global Monkeypox Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Monkeypox Therapeutics Forecasted Market Size by Type (2026-2031)
5 Monkeypox Therapeutics Breakdown Data by Application
5.1 Global Monkeypox Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Monkeypox Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Monkeypox Therapeutics Market Size (2020-2031)
6.2 North America Monkeypox Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Monkeypox Therapeutics Market Size by Country (2020-2025)
6.4 North America Monkeypox Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monkeypox Therapeutics Market Size (2020-2031)
7.2 Europe Monkeypox Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Monkeypox Therapeutics Market Size by Country (2020-2025)
7.4 Europe Monkeypox Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monkeypox Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Monkeypox Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Monkeypox Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Monkeypox Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monkeypox Therapeutics Market Size (2020-2031)
9.2 Latin America Monkeypox Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Monkeypox Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Monkeypox Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monkeypox Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Monkeypox Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Monkeypox Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Monkeypox Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chimerix Inc.
11.1.1 Chimerix Inc. Company Details
11.1.2 Chimerix Inc. Business Overview
11.1.3 Chimerix Inc. Monkeypox Therapeutics Introduction
11.1.4 Chimerix Inc. Revenue in Monkeypox Therapeutics Business (2020-2025)
11.1.5 Chimerix Inc. Recent Development
11.2 SIGA Technologies, Inc.
11.2.1 SIGA Technologies, Inc. Company Details
11.2.2 SIGA Technologies, Inc. Business Overview
11.2.3 SIGA Technologies, Inc. Monkeypox Therapeutics Introduction
11.2.4 SIGA Technologies, Inc. Revenue in Monkeypox Therapeutics Business (2020-2025)
11.2.5 SIGA Technologies, Inc. Recent Development
11.3 Emergent BioSolutions Inc.
11.3.1 Emergent BioSolutions Inc. Company Details
11.3.2 Emergent BioSolutions Inc. Business Overview
11.3.3 Emergent BioSolutions Inc. Monkeypox Therapeutics Introduction
11.3.4 Emergent BioSolutions Inc. Revenue in Monkeypox Therapeutics Business (2020-2025)
11.3.5 Emergent BioSolutions Inc. Recent Development
11.4 Bavarian Nordic A/S
11.4.1 Bavarian Nordic A/S Company Details
11.4.2 Bavarian Nordic A/S Business Overview
11.4.3 Bavarian Nordic A/S Monkeypox Therapeutics Introduction
11.4.4 Bavarian Nordic A/S Revenue in Monkeypox Therapeutics Business (2020-2025)
11.4.5 Bavarian Nordic A/S Recent Development
11.5 Hetero Drugs Limited
11.5.1 Hetero Drugs Limited Company Details
11.5.2 Hetero Drugs Limited Business Overview
11.5.3 Hetero Drugs Limited Monkeypox Therapeutics Introduction
11.5.4 Hetero Drugs Limited Revenue in Monkeypox Therapeutics Business (2020-2025)
11.5.5 Hetero Drugs Limited Recent Development
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Details
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Monkeypox Therapeutics Introduction
11.6.4 Mylan N.V. Revenue in Monkeypox Therapeutics Business (2020-2025)
11.6.5 Mylan N.V. Recent Development
11.7 Piramal Enterprises Limited
11.7.1 Piramal Enterprises Limited Company Details
11.7.2 Piramal Enterprises Limited Business Overview
11.7.3 Piramal Enterprises Limited Monkeypox Therapeutics Introduction
11.7.4 Piramal Enterprises Limited Revenue in Monkeypox Therapeutics Business (2020-2025)
11.7.5 Piramal Enterprises Limited Recent Development
11.8 Olon S.p.A.
11.8.1 Olon S.p.A. Company Details
11.8.2 Olon S.p.A. Business Overview
11.8.3 Olon S.p.A. Monkeypox Therapeutics Introduction
11.8.4 Olon S.p.A. Revenue in Monkeypox Therapeutics Business (2020-2025)
11.8.5 Olon S.p.A. Recent Development
11.9 Teva Pharmaceutical Industries Limited
11.9.1 Teva Pharmaceutical Industries Limited Company Details
11.9.2 Teva Pharmaceutical Industries Limited Business Overview
11.9.3 Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Introduction
11.9.4 Teva Pharmaceutical Industries Limited Revenue in Monkeypox Therapeutics Business (2020-2025)
11.9.5 Teva Pharmaceutical Industries Limited Recent Development
11.10 CIDIC Company Limited
11.10.1 CIDIC Company Limited Company Details
11.10.2 CIDIC Company Limited Business Overview
11.10.3 CIDIC Company Limited Monkeypox Therapeutics Introduction
11.10.4 CIDIC Company Limited Revenue in Monkeypox Therapeutics Business (2020-2025)
11.10.5 CIDIC Company Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Monkeypox Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Smallpox Vaccine
Table 3. Key Players of Antivirals
Table 4. Key Players of Vaccinia Immune Globulin (VIG)
Table 5. Global Monkeypox Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Monkeypox Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Monkeypox Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Monkeypox Therapeutics Market Share by Region (2020-2025)
Table 9. Global Monkeypox Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Monkeypox Therapeutics Market Share by Region (2026-2031)
Table 11. Monkeypox Therapeutics Market Trends
Table 12. Monkeypox Therapeutics Market Drivers
Table 13. Monkeypox Therapeutics Market Challenges
Table 14. Monkeypox Therapeutics Market Restraints
Table 15. Global Monkeypox Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Monkeypox Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Monkeypox Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Therapeutics as of 2024)
Table 18. Ranking of Global Top Monkeypox Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Monkeypox Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Monkeypox Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Monkeypox Therapeutics, Product and Application
Table 22. Global Key Players of Monkeypox Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Monkeypox Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Monkeypox Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Monkeypox Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Monkeypox Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Monkeypox Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Monkeypox Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Monkeypox Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Monkeypox Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Monkeypox Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Monkeypox Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Monkeypox Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Monkeypox Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Monkeypox Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Monkeypox Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Monkeypox Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Monkeypox Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Monkeypox Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Monkeypox Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Monkeypox Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Monkeypox Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Monkeypox Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Monkeypox Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Monkeypox Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Chimerix Inc. Company Details
Table 48. Chimerix Inc. Business Overview
Table 49. Chimerix Inc. Monkeypox Therapeutics Product
Table 50. Chimerix Inc. Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Chimerix Inc. Recent Development
Table 52. SIGA Technologies, Inc. Company Details
Table 53. SIGA Technologies, Inc. Business Overview
Table 54. SIGA Technologies, Inc. Monkeypox Therapeutics Product
Table 55. SIGA Technologies, Inc. Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 56. SIGA Technologies, Inc. Recent Development
Table 57. Emergent BioSolutions Inc. Company Details
Table 58. Emergent BioSolutions Inc. Business Overview
Table 59. Emergent BioSolutions Inc. Monkeypox Therapeutics Product
Table 60. Emergent BioSolutions Inc. Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Emergent BioSolutions Inc. Recent Development
Table 62. Bavarian Nordic A/S Company Details
Table 63. Bavarian Nordic A/S Business Overview
Table 64. Bavarian Nordic A/S Monkeypox Therapeutics Product
Table 65. Bavarian Nordic A/S Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Bavarian Nordic A/S Recent Development
Table 67. Hetero Drugs Limited Company Details
Table 68. Hetero Drugs Limited Business Overview
Table 69. Hetero Drugs Limited Monkeypox Therapeutics Product
Table 70. Hetero Drugs Limited Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Hetero Drugs Limited Recent Development
Table 72. Mylan N.V. Company Details
Table 73. Mylan N.V. Business Overview
Table 74. Mylan N.V. Monkeypox Therapeutics Product
Table 75. Mylan N.V. Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Mylan N.V. Recent Development
Table 77. Piramal Enterprises Limited Company Details
Table 78. Piramal Enterprises Limited Business Overview
Table 79. Piramal Enterprises Limited Monkeypox Therapeutics Product
Table 80. Piramal Enterprises Limited Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Piramal Enterprises Limited Recent Development
Table 82. Olon S.p.A. Company Details
Table 83. Olon S.p.A. Business Overview
Table 84. Olon S.p.A. Monkeypox Therapeutics Product
Table 85. Olon S.p.A. Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Olon S.p.A. Recent Development
Table 87. Teva Pharmaceutical Industries Limited Company Details
Table 88. Teva Pharmaceutical Industries Limited Business Overview
Table 89. Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Product
Table 90. Teva Pharmaceutical Industries Limited Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Teva Pharmaceutical Industries Limited Recent Development
Table 92. CIDIC Company Limited Company Details
Table 93. CIDIC Company Limited Business Overview
Table 94. CIDIC Company Limited Monkeypox Therapeutics Product
Table 95. CIDIC Company Limited Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 96. CIDIC Company Limited Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Monkeypox Therapeutics Picture
Figure 2. Global Monkeypox Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Monkeypox Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Smallpox Vaccine Features
Figure 5. Antivirals Features
Figure 6. Vaccinia Immune Globulin (VIG) Features
Figure 7. Global Monkeypox Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Monkeypox Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Monkeypox Therapeutics Report Years Considered
Figure 14. Global Monkeypox Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Monkeypox Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Monkeypox Therapeutics Market Share by Region: 2024 VS 2031
Figure 17. Global Monkeypox Therapeutics Market Share by Players in 2024
Figure 18. Global Top Monkeypox Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Therapeutics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Monkeypox Therapeutics Revenue in 2024
Figure 20. North America Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Monkeypox Therapeutics Market Share by Country (2020-2031)
Figure 22. United States Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Monkeypox Therapeutics Market Share by Country (2020-2031)
Figure 26. Germany Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Monkeypox Therapeutics Market Share by Region (2020-2031)
Figure 34. China Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Monkeypox Therapeutics Market Share by Country (2020-2031)
Figure 42. Mexico Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Monkeypox Therapeutics Market Share by Country (2020-2031)
Figure 46. Turkey Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Chimerix Inc. Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 50. SIGA Technologies, Inc. Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 51. Emergent BioSolutions Inc. Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 52. Bavarian Nordic A/S Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 53. Hetero Drugs Limited Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 54. Mylan N.V. Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 55. Piramal Enterprises Limited Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 56. Olon S.p.A. Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 57. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 58. CIDIC Company Limited Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Monkeypox Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Smallpox Vaccine
Table 3. Key Players of Antivirals
Table 4. Key Players of Vaccinia Immune Globulin (VIG)
Table 5. Global Monkeypox Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Monkeypox Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Monkeypox Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Monkeypox Therapeutics Market Share by Region (2020-2025)
Table 9. Global Monkeypox Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Monkeypox Therapeutics Market Share by Region (2026-2031)
Table 11. Monkeypox Therapeutics Market Trends
Table 12. Monkeypox Therapeutics Market Drivers
Table 13. Monkeypox Therapeutics Market Challenges
Table 14. Monkeypox Therapeutics Market Restraints
Table 15. Global Monkeypox Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Monkeypox Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Monkeypox Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Therapeutics as of 2024)
Table 18. Ranking of Global Top Monkeypox Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Monkeypox Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Monkeypox Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Monkeypox Therapeutics, Product and Application
Table 22. Global Key Players of Monkeypox Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Monkeypox Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Monkeypox Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Monkeypox Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Monkeypox Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Monkeypox Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Monkeypox Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Monkeypox Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Monkeypox Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Monkeypox Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Monkeypox Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Monkeypox Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Monkeypox Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Monkeypox Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Monkeypox Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Monkeypox Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Monkeypox Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Monkeypox Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Monkeypox Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Monkeypox Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Monkeypox Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Monkeypox Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Monkeypox Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Monkeypox Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Chimerix Inc. Company Details
Table 48. Chimerix Inc. Business Overview
Table 49. Chimerix Inc. Monkeypox Therapeutics Product
Table 50. Chimerix Inc. Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Chimerix Inc. Recent Development
Table 52. SIGA Technologies, Inc. Company Details
Table 53. SIGA Technologies, Inc. Business Overview
Table 54. SIGA Technologies, Inc. Monkeypox Therapeutics Product
Table 55. SIGA Technologies, Inc. Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 56. SIGA Technologies, Inc. Recent Development
Table 57. Emergent BioSolutions Inc. Company Details
Table 58. Emergent BioSolutions Inc. Business Overview
Table 59. Emergent BioSolutions Inc. Monkeypox Therapeutics Product
Table 60. Emergent BioSolutions Inc. Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Emergent BioSolutions Inc. Recent Development
Table 62. Bavarian Nordic A/S Company Details
Table 63. Bavarian Nordic A/S Business Overview
Table 64. Bavarian Nordic A/S Monkeypox Therapeutics Product
Table 65. Bavarian Nordic A/S Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Bavarian Nordic A/S Recent Development
Table 67. Hetero Drugs Limited Company Details
Table 68. Hetero Drugs Limited Business Overview
Table 69. Hetero Drugs Limited Monkeypox Therapeutics Product
Table 70. Hetero Drugs Limited Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Hetero Drugs Limited Recent Development
Table 72. Mylan N.V. Company Details
Table 73. Mylan N.V. Business Overview
Table 74. Mylan N.V. Monkeypox Therapeutics Product
Table 75. Mylan N.V. Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Mylan N.V. Recent Development
Table 77. Piramal Enterprises Limited Company Details
Table 78. Piramal Enterprises Limited Business Overview
Table 79. Piramal Enterprises Limited Monkeypox Therapeutics Product
Table 80. Piramal Enterprises Limited Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Piramal Enterprises Limited Recent Development
Table 82. Olon S.p.A. Company Details
Table 83. Olon S.p.A. Business Overview
Table 84. Olon S.p.A. Monkeypox Therapeutics Product
Table 85. Olon S.p.A. Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Olon S.p.A. Recent Development
Table 87. Teva Pharmaceutical Industries Limited Company Details
Table 88. Teva Pharmaceutical Industries Limited Business Overview
Table 89. Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Product
Table 90. Teva Pharmaceutical Industries Limited Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Teva Pharmaceutical Industries Limited Recent Development
Table 92. CIDIC Company Limited Company Details
Table 93. CIDIC Company Limited Business Overview
Table 94. CIDIC Company Limited Monkeypox Therapeutics Product
Table 95. CIDIC Company Limited Revenue in Monkeypox Therapeutics Business (2020-2025) & (US$ Million)
Table 96. CIDIC Company Limited Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Monkeypox Therapeutics Picture
Figure 2. Global Monkeypox Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Monkeypox Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Smallpox Vaccine Features
Figure 5. Antivirals Features
Figure 6. Vaccinia Immune Globulin (VIG) Features
Figure 7. Global Monkeypox Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Monkeypox Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Monkeypox Therapeutics Report Years Considered
Figure 14. Global Monkeypox Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Monkeypox Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Monkeypox Therapeutics Market Share by Region: 2024 VS 2031
Figure 17. Global Monkeypox Therapeutics Market Share by Players in 2024
Figure 18. Global Top Monkeypox Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Therapeutics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Monkeypox Therapeutics Revenue in 2024
Figure 20. North America Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Monkeypox Therapeutics Market Share by Country (2020-2031)
Figure 22. United States Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Monkeypox Therapeutics Market Share by Country (2020-2031)
Figure 26. Germany Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Monkeypox Therapeutics Market Share by Region (2020-2031)
Figure 34. China Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Monkeypox Therapeutics Market Share by Country (2020-2031)
Figure 42. Mexico Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Monkeypox Therapeutics Market Share by Country (2020-2031)
Figure 46. Turkey Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Monkeypox Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Chimerix Inc. Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 50. SIGA Technologies, Inc. Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 51. Emergent BioSolutions Inc. Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 52. Bavarian Nordic A/S Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 53. Hetero Drugs Limited Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 54. Mylan N.V. Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 55. Piramal Enterprises Limited Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 56. Olon S.p.A. Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 57. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 58. CIDIC Company Limited Revenue Growth Rate in Monkeypox Therapeutics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232